For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Aventis Pasteur Limited

USPTO Granted Patents = 75

% Expired Patents = 12.0

CIPO Patents = 2

EPO Patents = 4

Trademarks = 2

Forward Citations = 541

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

Michel Henri Klein (45 out of 164 patents)

Sheena M Loosmore (17 out of 68 patents)

Andrew D Murdin (14 out of 44 patents)

4. Yan-Ping Yang (13 out of 43 patents)

5. Pele Chong (12 out of 63 patents)

6. Raymond P Oomen (10 out of 50 patents)

7. Robin E Harkness (10 out of 22 patents)

8. Pamela L Dunn (10 out of 26 patents)

9. Benjamin Rovinski (9 out of 31 patents)

10. Anthony Bernard Schryvers (7 out of 30 patents)

11. Fei-Long Yao (6 out of 17 patents)

12. Roy Persson (6 out of 17 patents)

13. Shi-Xian Cao (5 out of 18 patents)

14. Ken Sasaki (5 out of 6 patents)

15. Shi Xian Cao (4 out of 11 patents)

Core Competencies:

Meningitis Vaccines

Chlamydial Vaccines

HIV-Like Particles

Immunogenic Compositions

Biodegradable Microparticles

Acellular Pertussis

Respiratory Syncytial Virus

Recombinant Proteins

Polysaccharide Conjugates

Adjuvant Compositions

Viral Vaccine Production

Transferrin Receptors

75 patents: Sort by Forward Citations

1. 8309100 - [object Object] (2012-11-13),

2. 7704513 - [object Object] (2010-04-27),

3. 7384768 - [object Object] (2008-06-10),

4. 7335370 - [object Object] (2008-02-26),

5. 7241449 - [object Object] (2007-07-10),

6. 7018637 - Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines (2006-03-28),

7. 7015033 - Co-expression of recombination proteins (2006-03-21),

8. 7008784 - Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles (2006-03-07),

9. 6974581 - [object Object] (2005-12-13),

10. 6933137 - Animal component free meningococcal polysaccharide fermentation and seedbank development (2005-08-23),

11. 6872814 - Chlamydia antigens and corresponding DNA fragments and uses thereof (2005-03-29),

12. 6855537 - Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor (2005-02-15),

13. 6849447 - Protective recombinant Haemophilus influenzae high molecular weight proteins (2005-02-01),

14. 6811783 - Immunogenic compositions for protection against chlamydial infection (2004-11-02),

15. 6808713 - Chlamydia antigens and corresponding DNA fragments and uses thereof (2004-10-26),

Aventis Pasteur Limited is a leading global provider of vaccines and biologics. With a strong commitment to public health, the company focuses on developing innovative solutions to prevent and treat infectious diseases. Aventis Pasteur Limited has a diverse portfolio of products that address a wide range of diseases, including influenza, meningitis, hepatitis, and polio. Their mission is to protect and improve the lives of individuals and communities worldwide through their expertise in research, manufacturing, and distribution of high-quality vaccines.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

75 Patents

#16 in Toronto

#166 in Canada

#9,983 in the World

Toronto, Canada

Aventis Pasteur Limited

Forward Citations = 541

84 inventors:

Michel Henri Klein (45 out of 164 patents)

Sheena M Loosmore (17 out of 68 patents)

Andrew D Murdin (14 out of 44 patents)

4. Yan-Ping Yang (13 out of 43 patents)

5. Pele Chong (12 out of 63 patents)

Please report any incorrect information to [email protected]

Loading…